Verified factor-similar pair

CSB vs QVAL

These two ETFs meet the same FF6 US comparison criteria: US-listed equity ETFs, the same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB HML RMW
Similarity score
82
Verified similar

The score combines exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

Quick Read

  • CSB has the higher backtested relative Sharpe (1.125 vs 0.641).
  • QVAL has the lower published fee (0.29% vs 0.40%).
  • QVAL is cheaper on dividend valuation (111 vs 134, where 100 is each fund's historical median).
  • CSB has the stronger regression fit (adjusted R-squared 0.949 vs 0.845).

These are screening signals, not a complete review of portfolio construction, turnover, taxes, or trading quality.

CSB

VictoryShares US Small Cap High Dividend Volatility Wtd ETF
SMB HML RMW
Adj. R2
0.949
Rel. Sharpe
1.125
Mkt beta
0.81
AUM
US$261M
MER
0.40%
Valuation
134

QVAL

Alpha Architect US Quantitative Value ETF
SMB HML RMW
Adj. R2
0.845
Rel. Sharpe
0.641
Mkt beta
1.08
AUM
US$506M
MER
0.29%
Valuation
111

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
CSB
+0.81
|t|
+16.8
QVAL
+0.42
|t|
+4.7
diff +0.39
HML
CSB
+0.35
|t|
+8.3
QVAL
+0.34
|t|
+4.2
diff +0.01
RMW
CSB
+0.35
|t|
+6.7
QVAL
+0.44
|t|
+4.4
diff -0.09
CMA
CSB
+0.04
|t|
+0.7
QVAL
+0.09
|t|
+0.7
diff -0.05
UMD
CSB
-0.05
|t|
-1.5
QVAL
-0.07
|t|
-1.1
diff +0.02

Why This Pair Matches

Exposure level
84
Exposure shape
96
Mkt beta diff
0.27
Rel. Sharpe diff
0.484

This comparison focuses on measured factor exposure. It does not compare holdings methodology, turnover, tax handling, or issuer process. Backtested relative Sharpe is a secondary signal rather than a stand-alone forecast. See methodology.

CSB fund page QVAL fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.